Hythiam Announces Presentation at BMO Capital Markets 8th Annual Focus on Healthcare Conference
Posted on: Tuesday, 29 July 2008, 09:01 CDT
Hythiam, Inc. (NASDAQ:HYTM) announced today that the Company will present at the upcoming BMO Capital Markets 8th Annual Focus on Healthcare Conference to be held August 5-6, 2008, at the Millennium Broadway Hotel in New York City.
Terren Peizer, Chairman and Chief Executive Officer of Hythiam, will present Tuesday, August 5th, at 3:30 PM Eastern Time. The presentation will be available as a live, audio webcast at: http://www.bmocm.com/conferences/2008healthcare/webcast/default.aspx. Hythiam's webcast will also be available on its website at www.hythiam.com, where it will be archived for 14 days following the conference.
About Hythiam(R)
Hythiam, Inc. provides through its Catasys(TM) offering, behavioral health management services to health plans, employers and unions through a network of licensed and company managed healthcare providers. Catasys offers integrated substance dependence solutions built around the patented PROMETA Treatment Program for alcoholism and stimulant dependence. The PROMETA Treatment Program, which integrates behavioral, nutritional, and medical components, is also available on a private-pay basis through licensed treatment providers and company managed treatment centers. Hythiam also researches, develops, licenses and commercializes innovative and proprietary physiological, nutritional, and behavioral treatment programs. Hythiam does not practice medicine or manufacture, distribute, or sell any medications and has no relationship with any manufacturers or distributors of medications used in the PROMETA Treatment Program. For further information, please visit www.hythiam.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history and lack of statistically significant formal research studies, the risk that treatment protocols might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the healthcare industry; and additional risks factors as discussed in the reports filed by the company with the Securities and Exchange Commission, which are available on its website at http://www.sec.gov.
Source: Business Wire
Related Articles
- Forterus Inc. Taps the Steve Wilkos Show to Help Build a National Client Base for A Better Tomorrow Treatment Center Inc., Its Behavioral Healthcare Subsidiary
- Body Language and Life Love &Amp; Health -- On the Path Productions Moves Forward With Expanded Programming
- Denton County, Texas to Implement and Fund Hythiam's First County Level PROMETA(R) Treatment Program for Substance Dependence Among Probationees
- Hythiam Secures Patents Underlying PROMETA Treatment Protocols in China and Korea
- Health Promotion Programs Hold Promise of Saving Medicare Money - Particularly When They Change Behavior, Thomson Healthcare Study Finds
- Hythiam Granted Alcoholism Treatment Patents for PROMETA By Russian and Ukraine Patent Offices
- The State of the Healthcare Industry: Looking Back and Planning Ahead
- Prestigious Residential Treatment Provider, Beau Monde Programs to Initially Offer PROMETA at Flagship Newport Beach Location; Hythiam Expands Access to PROMETA(TM) in Orange County, California
- Hythiam Expands Presence of PROMETA(TM) in California
- Effective Overweight and Obesity Treatment Requires a Triad of Behavioral, Nutritional and Physical Activity Modifications
 |
 |
User Comments (0)
RSS Feeds